300850050027

The barcode 300850050027 corresponds to a medication known as Emko-Refil, which is a generic formulation of the brand-name drug Emeko. This medication is classified as an estrogen or sex hormone and is primarily used for hormone replacement therapy in women undergoing menopause. Emko-Refil helps alleviate menopausal symptoms such as hot flashes, night sweats, and vaginal dryness.

As with any estrogen replacement therapy, Emko-Refil has certain warnings and concerns associated with its use:

1. Increased risk of blood clots: Estrogen therapy has been linked to a heightened risk of blood clots, which can result in serious health complications, such as deep vein thrombosis or pulmonary embolism.
2. Breast cancer risk: Prolonged use of estrogen replacement therapy may slightly elevate the risk of developing breast cancer in some women.
3. Endometrial cancer risk: Using unopposed estrogen (estrogen without progesterone) can lead to abnormal growth of the endometrium, increasing the risk of endometrial cancer, especially in women who have not had a hysterectomy.

Health-related disclaimers exist for products containing estrogens, as they may pose risks for women with certain medical histories or those taking specific medications.

In terms of pricing, a 28-day supply of Emko-Refil (30 mg estrogen) in the United States generally ranges between $20-$40 USD, though this can vary based on factors such as location, pharmacy, and insurance coverage.

This information is reflective of available data and may not account for the latest updates or specific product details.